Good clinical practices in the bioanalytical laboratory

Area of Science:

• Clinical Chemistry
• Pharmacokinetics
• Regulatory Science

Background:

• Good Clinical Practice (GCP) guidelines exist but their application in bioanalytical laboratories is often unclear.
• Key aspects like patient confidentiality, informed consent, and unblinding procedures are not explicitly detailed by regulatory bodies for bioanalysis.
• Gaps in Standard Operating Procedures (SOPs) exist in many bioanalytical labs regarding clinical sample analysis.

Purpose of the Study:

• To identify and clarify GCP aspects relevant to bioanalytical laboratories.
• To address and resolve ambiguities in applying GCP to the bioanalytical setting.
• To bridge the gap between general GCP and specific bioanalytical laboratory practices.

Main Methods:

• Review of existing Good Clinical Practice guidelines.
• Analysis of US FDA regulations pertaining to bioanalysis.
• Identification of common practices and challenges in bioanalytical laboratories.

Main Results:

• Specific GCP principles applicable to bioanalytical sample handling and analysis were identified.
• Areas requiring clarification, such as subject withdrawal and repeat analysis protocols, were highlighted.
• Differences in sponsor and contract research organization responsibilities were examined.

Conclusions:

• Bioanalytical laboratories need to integrate specific GCP principles into their SOPs.
• Clearer regulatory articulation is needed for GCP in the bioanalytical context.
• Addressing these gaps ensures data integrity and patient protection in clinical trials.